Subpopulations of extracellular vesicles and their therapeutic potential

Subpopulations of extracellular vesicles and their therapeutic potential Extracellular vesicles (EVs), such as exosomes and microvesicles, have over the last 10–15 years been recognized to convey key messages in the molecular communication between cells. Indeed, EVs have the capacity to shuttle proteins, lipids, and nucleotides such as RNA between cells, leading to an array of functional changes in the recipient cells. Importantly, the EV secretome changes significantly in diseased cells and under conditions of cellular stress. More recently, it has become evident that the EV secretome is exceptionally diverse, with many different types of EVs being released by a single cell type, and these EVs can be described in terms of differences in density, molecular cargos, and morphology. This review will discuss the diversity of EVs, will introduce some suggestions for how to categorize them, and will propose how EVs and their subpopulations might be used for very different therapeutic purposes. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Molecular Aspects of Medicine Elsevier

Subpopulations of extracellular vesicles and their therapeutic potential

14 pages
Read Article

Loading next page...
 
/lp/elsevier/subpopulations-of-extracellular-vesicles-and-their-therapeutic-ysNsGpz0pI
Publisher
Elsevier
Copyright
Copyright © 2018 Elsevier Ltd
ISSN
0098-2997
eISSN
1872-9452
D.O.I.
10.1016/j.mam.2018.02.002
Publisher site
See Article on Publisher Site

Abstract

Extracellular vesicles (EVs), such as exosomes and microvesicles, have over the last 10–15 years been recognized to convey key messages in the molecular communication between cells. Indeed, EVs have the capacity to shuttle proteins, lipids, and nucleotides such as RNA between cells, leading to an array of functional changes in the recipient cells. Importantly, the EV secretome changes significantly in diseased cells and under conditions of cellular stress. More recently, it has become evident that the EV secretome is exceptionally diverse, with many different types of EVs being released by a single cell type, and these EVs can be described in terms of differences in density, molecular cargos, and morphology. This review will discuss the diversity of EVs, will introduce some suggestions for how to categorize them, and will propose how EVs and their subpopulations might be used for very different therapeutic purposes.

Journal

Molecular Aspects of Medicine – Elsevier

Published: Apr 1, 2018

References

  • Identification of distinct populations of prostasomes that differentially express prostate stem cell antigen, annexin A1, and GLIPR2 in humans
    Aalberts, M.; van Dissel-Emiliani, F.M.; van Adrichem, N.P.; van Wijnen, M.; Wauben, M.H.; Stout, T.A.; Stoorvogel, W.
  • Exosomes with immune modulatory features are present in human breast milk
    Admyre, C.; Johansson, S.M.; Qazi, K.R.; Filen, J.J.; Lahesmaa, R.; Norman, M.; Neve, E.P.; Scheynius, A.; Gabrielsson, S.
  • Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
    Alvarez-Erviti, L.; Seow, Y.; Yin, H.; Betts, C.; Lakhal, S.; Wood, M.J.
  • Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration
    Arraud, N.; Linares, R.; Tan, S.; Gounou, C.; Pasquet, J.M.; Mornet, S.; Brisson, A.R.
  • Syndecan-syntenin-ALIX regulates the biogenesis of exosomes
    Baietti, M.F.; Zhang, Z.; Mortier, E.; Melchior, A.; Degeest, G.; Geeraerts, A.; Ivarsson, Y.; Depoortere, F.; Coomans, C.; Vermeiren, E.; Zimmermann, P.; David, G.
  • Tumour microvesicles contain retrotransposon elements and amplified oncogene sequences
    Balaj, L.; Lessard, R.; Dai, L.; Cho, Y.J.; Pomeroy, S.L.; Breakefield, X.O.; Skog, J.
  • Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC
    Besse, B.; Charrier, M.; Lapierre, V.; Dansin, E.; Lantz, O.; Planchard, D.; Le Chevalier, T.; Livartoski, A.; Barlesi, F.; Laplanche, A.; Ploix, S.; Vimond, N.; Peguillet, I.; Thery, C.; Lacroix, L.; Zoernig, I.; Dhodapkar, K.; Dhodapkar, M.; Viaud, S.; Soria, J.C.; Reiners, K.S.; Pogge von Strandmann, E.; Vely, F.; Rusakiewicz, S.; Eggermont, A.; Pitt, J.M.; Zitvogel, L.; Chaput, N.
  • Nuclear RNA is extruded from apoptotic cells
    Biggiogera, M.; Bottone, M.G.; Pellicciari, C.
  • Diverse subpopulations of vesicles secreted by different intracellular mechanisms are present in exosome preparations obtained by differential ultracentrifugation
    Bobrie, A.; Colombo, M.; Krumeich, S.; Raposo, G.; Théry, C.
  • Exosomes and HIV Gag bud from endosome-like domains of the T cell plasma membrane
    Booth, A.M.; Fang, Y.; Fallon, J.K.; Yang, J.M.; Hildreth, J.E.; Gould, S.J.
  • Cell derived liposomes expressing CCR5 as a new targeted drug-delivery system for HIV infected cells
    Bronshtein, T.; Toledano, N.; Danino, D.; Pollack, S.; Machluf, M.
  • Distinct lipid compositions of two types of human prostasomes
    Brouwers, J.F.; Aalberts, M.; Jansen, J.W.; van Niel, G.; Wauben, M.H.; Stout, T.A.; Helms, J.B.; Stoorvogel, W.
  • Mesenchymal stem cell-derived microvesicles protect against acute tubular injury
    Bruno, S.; Grange, C.; Deregibus, M.C.; Calogero, R.A.; Saviozzi, S.; Collino, F.; Morando, L.; Busca, A.; Falda, M.; Bussolati, B.; Tetta, C.; Camussi, G.
  • Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells
    Cai, J.; Han, Y.; Ren, H.; Chen, C.; He, D.; Zhou, L.; Eisner, G.M.; Asico, L.D.; Jose, P.A.; Zeng, C.
  • Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes
    Casciola-Rosen, L.A.; Anhalt, G.; Rosen, A.
  • The biological significance of the thromboplastic protein of blood
    Chargaff, E.; West, R.
  • Exosome and microvesicle-enriched fractions isolated from mesenchymal stem cells by gradient separation showed different molecular signatures and functions on renal tubular epithelial cells
    Collino, F.; Pomatto, M.; Bruno, S.; Lindoso, R.S.; Tapparo, M.; Sicheng, W.; Quesenberry, P.; Camussi, G.
  • Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles
    Colombo, M.; Moita, C.; van Niel, G.; Kowal, J.; Vigneron, J.; Benaroch, P.; Manel, N.; Moita, L.F.; Thery, C.; Raposo, G.
  • Biogenesis, secretion, and intercellular interactions of exosomes and other extracellular vesicles
    Colombo, M.; Raposo, G.; Thery, C.
  • Distinct RNA profiles in subpopulations of extracellular vesicles: apoptotic bodies, microvesicles and exosomes
    Crescitelli, R.; Lässer, C.; Szabo, T.G.; Kittel, A.; Eldh, M.; Dianzani, I.; Buzás, E.I.; Lötvall, J.
  • Syncytiotrophoblast vesicles show altered micro-RNA and haemoglobin content after ex-vivo perfusion of placentas with haemoglobin to mimic preeclampsia
    Cronqvist, T.; Salje, K.; Familari, M.; Guller, S.; Schneider, H.; Gardiner, C.; Sargent, I.L.; Redman, C.W.; Morgelin, M.; Akerstrom, B.; Gram, M.; Hansson, S.R.
  • Systemic administration of human bone marrow-derived mesenchymal stromal cell extracellular vesicles ameliorates Aspergillus hyphal extract-induced allergic airway inflammation in immunocompetent mice
    Cruz, F.F.; Borg, Z.D.; Goodwin, M.; Sokocevic, D.; Wagner, D.E.; Coffey, A.; Antunes, M.; Robinson, K.L.; Mitsialis, S.A.; Kourembanas, S.; Thane, K.; Hoffman, A.M.; McKenna, D.H.; Rocco, P.R.; Weiss, D.J.
  • The influence of rotor type and centrifugation time on the yield and purity of extracellular vesicles
    Cvjetkovic, A.; Lötvall, J.; Lässer, C.
  • Detailed analysis of protein topology of extracellular vesicles-evidence of unconventional membrane protein orientation
    Cvjetkovic, A.; Jang, S.C.; Konecna, B.; Hoog, J.L.; Sihlbom, C.; Lasser, C.; Lotvall, J.
  • Extracellular vesicles in motion
    Cvjetkovic, A.; Crescitelli, R.; Lässer, C.; Zabeo, D.; Widlund, P.; Nyström, T.; Höög, J.L.; Lötvall, J.
  • Current prospects for RNA interference-based therapies
    Davidson, B.L.; McCray, P.B.
  • Exosome Display technology: applications to the development of new diagnostics and therapeutics
    Delcayre, A.; Estelles, A.; Sperinde, J.; Roulon, T.; Paz, P.; Aguilar, B.; Villanueva, J.; Khine, S.; Le Pecq, J.B.
  • Exosome-mediated delivery of hydrophobically modified siRNA for huntingtin mRNA silencing
    Didiot, M.C.; Hall, L.M.; Coles, A.H.; Haraszti, R.A.; Godinho, B.M.; Chase, K.; Sapp, E.; Ly, S.; Alterman, J.F.; Hassler, M.R.; Echeverria, D.; Raj, L.; Morrissey, D.V.; DiFiglia, M.; Aronin, N.; Khvorova, A.
  • Viral late domains
    Freed, E.O.
  • Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury
    Gatti, S.; Bruno, S.; Deregibus, M.C.; Sordi, A.; Cantaluppi, V.; Tetta, C.; Camussi, G.
  • Emergent properties of extracellular vesicles: a holistic approach to decode the complexity of intercellular communication networks
    Gho, Y.S.; Lee, C.
  • Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy
    Goh, W.J.; Lee, C.K.; Zou, S.; Woon, E.C.; Czarny, B.; Pastorin, G.
  • As we wait: coping with an imperfect nomenclature for extracellular vesicles
    Gould, S.J.; Raposo, G.
  • Active Wnt proteins are secreted on exosomes
    Gross, J.C.; Chaudhary, V.; Bartscherer, K.; Boutros, M.
  • Astrocytes and Glioblastoma cells release exosomes carrying mtDNA
    Guescini, M.; Genedani, S.; Stocchi, V.; Agnati, L.F.
  • HSP60 trafficking in adult cardiac myocytes: role of the exosomal pathway. American journal of physiology
    Gupta, S.; Knowlton, A.A.
  • Membrane vesicles, current state-of-the-art: emerging role of extracellular vesicles
    Gyorgy, B.; Szabo, T.G.; Pasztoi, M.; Pal, Z.; Misjak, P.; Aradi, B.; Laszlo, V.; Pallinger, E.; Pap, E.; Kittel, A.; Nagy, G.; Falus, A.; Buzas, E.I.
  • Therapeutic applications of extracellular vesicles: clinical promise and open questions
    Gyorgy, B.; Hung, M.E.; Breakefield, X.O.; Leonard, J.N.
  • Exosomes increase the therapeutic index of doxorubicin in breast and ovarian cancer mouse models
    Hadla, M.; Palazzolo, S.; Corona, G.; Caligiuri, I.; Canzonieri, V.; Toffoli, G.; Rizzolio, F.
  • Stem cell-based therapies for ischemic stroke
    Hao, L.; Zou, Z.; Tian, H.; Zhang, Y.; Zhou, H.; Liu, L.
  • Effect of pegylation on pharmaceuticals
    Harris, J.M.; Chess, R.B.
  • Diversity of extracellular vesicles in human ejaculates revealed by cryo-electron microscopy
    Höög, J.L.; Lötvall, J.
  • Exosome secretion is enhanced by invadopodia and drives invasive behavior
    Hoshino, D.; Kirkbride, K.C.; Costello, K.; Clark, E.S.; Sinha, S.; Grega-Larson, N.; Tyska, M.J.; Weaver, A.M.
  • Regulation of exosome secretion by Rab35 and its GTPase-activating proteins TBC1D10A-C
    Hsu, C.; Morohashi, Y.; Yoshimura, S.; Manrique-Hoyos, N.; Jung, S.; Lauterbach, M.A.; Bakhti, M.; Gronborg, M.; Mobius, W.; Rhee, J.; Barr, F.A.; Simons, M.
  • Stem cell transplantation for autoimmune diseases
    Hugle, T.; Daikeler, T.
  • Endosome maturation
    Huotari, J.; Helenius, A.
  • Effects of inhibiting VPS4 support a general role for ESCRTs in extracellular vesicle biogenesis
    Jackson, C.E.; Scruggs, B.S.; Schaffer, J.E.; Hanson, P.I.
  • Bioinspired exosome-mimetic nanovesicles for targeted delivery of chemotherapeutics to malignant tumors
    Jang, S.C.; Kim, O.Y.; Yoon, C.M.; Choi, D.S.; Roh, T.Y.; Park, J.; Nilsson, J.; Lotvall, J.; Kim, Y.K.; Gho, Y.S.
  • A subgroup of mitochondrial extracellular vesicles discovered in human melanoma tissues are detectable in patient blood
    Jang, S.C.; Crescitelli, R.; Cvjetkovic, A.; Belgrano, V.; Olofsson Bagge, R.; Höög, L.J.; Sundfeldt, K.; Ochiya, T.; Kalluri, R.; Lötvall, J.
  • Comparative analysis of discrete exosome fractions obtained by differential centrifugation
    Jeppesen, D.K.; Hvam, M.L.; Primdahl-Bengtson, B.; Boysen, A.T.; Whitehead, B.; Dyrskjot, L.; Orntoft, T.F.; Howard, K.A.; Ostenfeld, M.S.
  • Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers
    Jo, W.; Jeong, D.; Kim, J.; Cho, S.; Jang, S.C.; Han, C.; Kang, J.Y.; Gho, Y.S.; Park, J.
  • Large-scale generation of cell-derived nanovesicles
    Jo, W.; Kim, J.; Yoon, J.; Jeong, D.; Cho, S.; Jeong, H.; Yoon, Y.J.; Kim, S.C.; Gho, Y.S.; Park, J.
  • Focus on extracellular vesicles: introducing the next small big thing
    Kalra, H.; Drummen, G.P.; Mathivanan, S.
  • Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
    Kamerkar, S.; LeBleu, V.S.; Sugimoto, H.; Yang, S.; Ruivo, C.F.; Melo, S.A.; Lee, J.J.; Kalluri, R.
  • "Tolerosomes" are produced by intestinal epithelial cells
    Karlsson, M.; Lundin, S.; Dahlgren, U.; Kahu, H.; Pettersson, I.; Telemo, E.
  • Recent progress in development of siRNA delivery vehicles for cancer therapy
    Kim, H.J.; Kim, A.; Miyata, K.; Kataoka, K.
  • Development of exosome-encapsulated paclitaxel to overcome MDR in cancer cells
    Kim, M.S.; Haney, M.J.; Zhao, Y.; Mahajan, V.; Deygen, I.; Klyachko, N.L.; Inskoe, E.; Piroyan, A.; Sokolsky, M.; Okolie, O.; Hingtgen, S.D.; Kabanov, A.V.; Batrakova, E.V.
  • Extracellular vesicle mimetics: novel alternatives to extracellular vesicle-based theranostics, drug delivery, and vaccines
    Kim, O.Y.; Lee, J.; Gho, Y.S.
  • Adipose stem cell-derived nanovesicles inhibit emphysema primarily via an FGF2-dependent pathway
    Kim, Y.S.; Kim, J.Y.; Cho, R.; Shin, D.M.; Lee, S.W.; Oh, Y.M.
  • Electroporation-induced siRNA precipitation obscures the efficiency of siRNA loading into extracellular vesicles
    Kooijmans, S.A.; Stremersch, S.; Braeckmans, K.; de Smedt, S.C.; Hendrix, A.; Wood, M.J.; Schiffelers, R.M.; Raemdonck, K.; Vader, P.
  • PEGylated and targeted extracellular vesicles display enhanced cell specificity and circulation time
    Kooijmans, S.A.A.; Fliervoet, L.A.L.; van der Meel, R.; Fens, M.; Heijnen, H.F.G.; van Bergen En Henegouwen, P.M.P.; Vader, P.; Schiffelers, R.M.
  • Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes
    Kowal, J.; Arras, G.; Colombo, M.; Jouve, M.; Morath, J.P.; Primdal-Bengtson, B.; Dingli, F.; Loew, D.; Tkach, M.; Thery, C.
  • Exosome secreted by MSC reduces myocardial ischemia/reperfusion injury
    Lai, R.C.; Arslan, F.; Lee, M.M.; Sze, N.S.; Choo, A.; Chen, T.S.; Salto-Tellez, M.; Timmers, L.; Lee, C.N.; El Oakley, R.M.; Pasterkamp, G.; de Kleijn, D.P.; Lim, S.K.
  • Exosome nanotechnology: an emerging paradigm shift in drug delivery: exploitation of exosome nanovesicles for systemic in vivo delivery of RNAi heralds new horizons for drug delivery across biological barriers
    Lakhal, S.; Wood, M.J.
  • Two distinct extracellular RNA signatures released by a single cell type identified by microarray and next-generation sequencing
    Lässer, C.; Shelke, G.V.; Yeri, A.; Kim, D.K.; Crescitelli, R.; Raimondo, S.; Sjostrand, M.; Gho, Y.S.; Van Keuren Jensen, K.; Lotvall, J.
  • Different gDNA content in the subpopulations of prostate cancer extracellular vesicles: apoptotic bodies, microvesicles, and exosomes
    Lazaro-Ibanez, E.; Sanz-Garcia, A.; Visakorpi, T.; Escobedo-Lucea, C.; Siljander, P.; Ayuso-Sacido, A.; Yliperttula, M.
  • Distinct prostate cancer-related mRNA cargo in extracellular vesicle subsets from prostate cell lines
    Lazaro-Ibanez, E.; Lunavat, T.R.; Jang, S.C.; Escobedo-Lucea, C.; Oliver-De La Cruz, J.; Siljander, P.; Lotvall, J.; Yliperttula, M.
  • Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study
    Le Blanc, K.; Frassoni, F.; Ball, L.; Locatelli, F.; Roelofs, H.; Lewis, I.; Lanino, E.; Sundberg, B.; Bernardo, M.E.; Remberger, M.; Dini, G.; Egeler, R.M.; Bacigalupo, A.; Fibbe, W.; Ringden, O.
  • Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis
    Li, T.; Yan, Y.; Wang, B.; Qian, H.; Zhang, X.; Shen, L.; Wang, M.; Zhou, Y.; Zhu, W.; Li, W.; Xu, W.
  • Photoexcited CRY2 interacts with CIB1 to regulate transcription and floral initiation in Arabidopsis
    Liu, H.; Yu, X.; Li, K.; Klejnot, J.; Yang, H.; Lisiero, D.; Lin, C.
  • Small RNA deep sequencing discriminates subsets of extracellular vesicles released by melanoma cells - evidence of unique microRNA cargos
    Lunavat, T.R.; Cheng, L.; Kim, D.K.; Bhadury, J.; Jang, S.C.; Lasser, C.; Sharples, R.A.; Lopez, M.D.; Nilsson, J.; Gho, Y.S.; Hill, A.F.; Lotvall, J.
  • RNAi delivery by exosome-mimetic nanovesicles - implications for targeting c-Myc in cancer
    Lunavat, T.R.; Jang, S.C.; Nilsson, L.; Park, H.T.; Repiska, G.; Lasser, C.; Nilsson, J.A.; Gho, Y.S.; Lotvall, J.
  • Release of extracellular membrane particles carrying the stem cell marker prominin-1 (CD133) from neural progenitors and other epithelial cells
    Marzesco, A.M.; Janich, P.; Wilsch-Brauninger, M.; Dubreuil, V.; Langenfeld, K.; Corbeil, D.; Huttner, W.B.
  • Exosomes: extracellular organelles important in intercellular communication
    Mathivanan, S.; Ji, H.; Simpson, R.J.
  • Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA
    Morishita, M.; Takahashi, Y.; Matsumoto, A.; Nishikawa, M.; Takakura, Y.
  • Routes and mechanisms of extracellular vesicle uptake
    Mulcahy, L.A.; Pink, R.C.; Carter, D.R.
  • Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein
    Nabhan, J.F.; Hu, R.; Oh, R.S.; Cohen, S.N.; Lu, Q.
  • PEG-modified gold nanorods with a stealth character for in vivo applications
    Niidome, T.; Yamagata, M.; Okamoto, Y.; Akiyama, Y.; Takahashi, H.; Kawano, T.; Katayama, Y.; Niidome, Y.
  • Deep sequencing of RNA from immune cell-derived vesicles uncovers the selective incorporation of small non-coding RNA biotypes with potential regulatory functions
    Nolte-'t Hoen, E.N.; Buermans, H.P.; Waasdorp, M.; Stoorvogel, W.; Wauben, M.H.; t Hoen, P.A.
  • Functional delivery of lipid-conjugated siRNA by extracellular vesicles
    O'Loughlin, A.J.; Mager, I.; de Jong, O.G.; Varela, M.A.; Schiffelers, R.M.; El Andaloussi, S.; Wood, M.J.A.; Vader, P.
  • In vivo differentiation of therapeutic insulin-producing cells from bone marrow cells via extracellular vesicle-mimetic nanovesicles
    Oh, K.; Kim, S.R.; Kim, D.K.; Seo, M.W.; Lee, C.; Lee, H.M.; Oh, J.E.; Choi, E.Y.; Lee, D.S.; Gho, Y.S.; Park, K.S.
  • Systemically injected exosomes targeted to EGFR deliver antitumor microRNA to breast cancer cells
    Ohno, S.; Takanashi, M.; Sudo, K.; Ueda, S.; Ishikawa, A.; Matsuyama, N.; Fujita, K.; Mizutani, T.; Ohgi, T.; Ochiya, T.; Gotoh, N.; Kuroda, M.
  • Rab27a and Rab27b control different steps of the exosome secretion pathway
    Ostrowski, M.; Carmo, N.B.; Krumeich, S.; Fanget, I.; Raposo, G.; Savina, A.; Moita, C.F.; Schauer, K.; Hume, A.N.; Freitas, R.P.; Goud, B.; Benaroch, P.; Hacohen, N.; Fukuda, M.; Desnos, C.; Seabra, M.C.; Darchen, F.; Amigorena, S.; Moita, L.F.; Thery, C.
  • MicroRNAs are exported from malignant cells in customized particles
    Palma, J.; Yaddanapudi, S.C.; Pigati, L.; Havens, M.A.; Jeong, S.; Weiner, G.A.; Weimer, K.M.; Stern, B.; Hastings, M.L.; Duelli, D.M.
  • Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery
    Pascucci, L.; Cocce, V.; Bonomi, A.; Ami, D.; Ceccarelli, P.; Ciusani, E.; Vigano, L.; Locatelli, A.; Sisto, F.; Doglia, S.M.; Parati, E.; Bernardo, M.E.; Muraca, M.; Alessandri, G.; Bondiolotti, G.; Pessina, A.
  • Functional delivery of viral miRNAs via exosomes
    Pegtel, D.M.; Cosmopoulos, K.; Thorley-Lawson, D.A.; van Eijndhoven, M.A.; Hopmans, E.S.; Lindenberg, J.L.; de Gruijl, T.D.; Wurdinger, T.; Middeldorp, J.M.
  • Structural heterogeneity and protein composition of exosome-like vesicles (prostasomes) in human semen
    Poliakov, A.; Spilman, M.; Dokland, T.; Amling, C.L.; Mobley, J.A.
  • Membrane vesicles shed by murine melanoma cells selectively inhibit the expression of Ia antigen by macrophages
    Poutsiaka, D.D.; Schroder, E.W.; Taylor, D.D.; Levy, E.M.; Black, P.H.
  • Nedd4 family-interacting protein 1 (Ndfip1) is required for the exosomal secretion of Nedd4 family proteins
    Putz, U.; Howitt, J.; Lackovic, J.; Foot, N.; Kumar, S.; Silke, J.; Tan, S.S.
  • Extracellular vesicles: exosomes, microvesicles, and friends
    Raposo, G.; Stoorvogel, W.
  • B lymphocytes secrete antigen-presenting vesicles
    Raposo, G.; Nijman, H.W.; Stoorvogel, W.; Liejendekker, R.; Harding, C.V.; Melief, C.J.; Geuze, H.J.
  • Embryonic stem cell-derived microvesicles reprogram hematopoietic progenitors: evidence for horizontal transfer of mRNA and protein delivery
    Ratajczak, J.; Miekus, K.; Kucia, M.; Zhang, J.; Reca, R.; Dvorak, P.; Ratajczak, M.Z.
  • Bone marrow-derived mesenchymal stem cells repaired but did not prevent gentamicin-induced acute kidney injury through paracrine effects in rats
    Reis, L.A.; Borges, F.T.; Simoes, M.J.; Borges, A.A.; Sinigaglia-Coimbra, R.; Schor, N.
  • Stem cell extracellular vesicles: extended messages of regeneration
    Riazifar, M.; Pone, E.J.; Lotvall, J.; Zhao, W.
  • The prostasome: its secretion and function in man
    Ronquist, G.; Brody, I.
  • Human prostasomes contain chromosomal DNA
    Ronquist, K.G.; Ronquist, G.; Carlsson, L.; Larsson, A.
  • Prostasomal DNA characterization and transfer into human sperm
    Ronquist, G.K.; Larsson, A.; Ronquist, G.; Isaksson, A.; Hreinsson, J.; Carlsson, L.; Stavreus-Evers, A.
  • Prostasomes from four different species are able to produce extracellular adenosine triphosphate (ATP)
    Ronquist, K.G.; Ek, B.; Morrell, J.; Stavreus-Evers, A.; Strom Holst, B.; Humblot, P.; Ronquist, G.; Larsson, A.
  • Microvesicle- and exosome-mediated drug delivery enhances the cytotoxicity of Paclitaxel in autologous prostate cancer cells
    Saari, H.; Lazaro-Ibanez, E.; Viitala, T.; Vuorimaa-Laukkanen, E.; Siljander, P.; Yliperttula, M.
  • The exosome pathway in K562 cells is regulated by Rab11
    Savina, A.; Vidal, M.; Colombo, M.I.
  • Human mast cells release extracellular vesilce-associated DNA
    Shelke, G.V.; Jang, S.C.; Yin, Y.; Lässer, C.; Lötvall, J.
  • alphaB crystallin is apically secreted within exosomes by polarized human retinal pigment epithelium and provides neuroprotection to adjacent cells
    Sreekumar, P.G.; Kannan, R.; Kitamura, M.; Spee, C.; Barron, E.; Ryan, S.J.; Hinton, D.R.
  • Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells
    Srivastava, A.; Amreddy, N.; Babu, A.; Panneerselvam, J.; Mehta, M.; Muralidharan, R.; Chen, A.; Zhao, Y.D.; Razaq, M.; Riedinger, N.; Kim, H.; Liu, S.; Wu, S.; Abdel-Mageed, A.B.; Munshi, A.; Ramesh, R.
  • Engineered exosomes as vehicles for biologically active proteins
    Sterzenbach, U.; Putz, U.; Low, L.H.; Silke, J.; Tan, S.S.; Howitt, J.
  • A novel nanoparticle drug delivery system: the anti-inflammatory activity of curcumin is enhanced when encapsulated in exosomes
    Sun, D.; Zhuang, X.; Xiang, X.; Liu, Y.; Zhang, S.; Liu, C.; Barnes, S.; Grizzle, W.; Miller, D.; Zhang, H.G.
  • Low active loading of cargo into engineered extracellular vesicles results in inefficient miRNA mimic delivery
    Sutaria, D.S.; Jiang, J.; Elgamal, O.A.; Pomeroy, S.M.; Badawi, M.; Zhu, X.; Pavlovicz, R.; Azevedo-Pouly, A.C.P.; Chalmers, J.; Li, C.; Phelps, M.A.; Schmittgen, T.D.
  • Exosome secretion of dendritic cells is regulated by Hrs, an ESCRT-0 protein
    Tamai, K.; Tanaka, N.; Nakano, T.; Kakazu, E.; Kondo, Y.; Inoue, J.; Shiina, M.; Fukushima, K.; Hoshino, T.; Sano, K.; Ueno, Y.; Shimosegawa, T.; Sugamura, K.
  • Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models
    Tan, C.Y.; Lai, R.C.; Wong, W.; Dan, Y.Y.; Lim, S.K.; Ho, H.K.
  • Two distinct populations of exosomes are released from LIM1863 colon carcinoma cell-derived organoids
    Tauro, B.J.; Greening, D.W.; Mathias, R.A.; Mathivanan, S.; Ji, H.; Simpson, R.J.
  • Membrane vesicles as conveyors of immune responses. Nature reviews
    Thery, C.; Ostrowski, M.; Segura, E.
  • A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
    Tian, Y.; Li, S.; Song, J.; Ji, T.; Zhu, M.; Anderson, G.J.; Wei, J.; Nie, G.
  • Reconstructed stem cell nanoghosts: a natural tumor targeting platform
    Toledano Furman, N.E.; Lupu-Haber, Y.; Bronshtein, T.; Kaneti, L.; Letko, N.; Weinstein, E.; Baruch, L.; Machluf, M.
  • Proteomic characterization of macro-, micro- and nano-extracellular vesicles derived from the same first trimester placenta: relevance for feto-maternal communication
    Tong, M.; Kleffmann, T.; Pradhan, S.; Johansson, C.L.; DeSousa, J.; Stone, P.R.; James, J.L.; Chen, Q.; Chamley, L.W.
  • Ceramide triggers budding of exosome vesicles into multivesicular endosomes
    Trajkovic, K.; Hsu, C.; Chiantia, S.; Rajendran, L.; Wenzel, D.; Wieland, F.; Schwille, P.; Brugger, B.; Simons, M.
  • Exfoliation of membrane ecto-enzymes in the form of micro-vesicles
    Trams, E.G.; Lauter, C.J.; Salem, N.; Heine, U.
  • Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells
    Valadi, H.; Ekström, K.; Bossios, A.; Sjöstrand, M.; Lee, J.J.; Lötvall, J.O.
  • Classification, functions, and clinical relevance of extracellular vesicles
    van der Pol, E.; Boing, A.N.; Harrison, P.; Sturk, A.; Nieuwland, R.
  • Microvesicles and exosomes: opportunities for cell-derived membrane vesicles in drug delivery
    van Dommelen, S.M.; Vader, P.; Lakhal, S.; Kooijmans, S.A.; van Solinge, W.W.; Wood, M.J.; Schiffelers, R.M.
  • Cardiomyocyte microvesicles contain DNA/RNA and convey biological messages to target cells
    Waldenstrom, A.; Genneback, N.; Hellman, U.; Ronquist, G.
  • Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy
    Wang, L.; Cong, X.; Liu, G.; Zhou, J.; Bai, B.; Li, Y.; Bai, W.; Li, M.; Ji, H.; Zhu, D.; Wu, M.; Liu, Y.
  • Delivery of therapeutic agents by nanoparticles made of grapefruit-derived lipids
    Wang, Q.; Zhuang, X.; Mu, J.; Deng, Z.B.; Jiang, H.; Zhang, L.; Xiang, X.; Wang, B.; Yan, J.; Miller, D.; Zhang, H.G.
  • Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting
    Wiklander, O.P.; Nordin, J.Z.; O'Loughlin, A.; Gustafsson, Y.; Corso, G.; Mager, I.; Vader, P.; Lee, Y.; Sork, H.; Seow, Y.; Heldring, N.; Alvarez-Erviti, L.; Smith, C.I.; Le Blanc, K.; Macchiarini, P.; Jungebluth, P.; Wood, M.J.; Andaloussi, S.E.
  • Cells release subpopulations of exosomes with distinct molecular and biological properties
    Willms, E.; Johansson, H.J.; Mager, I.; Lee, Y.; Blomberg, K.E.; Sadik, M.; Alaarg, A.; Smith, C.I.; Lehtio, J.; El Andaloussi, S.; Wood, M.J.; Vader, P.
  • Bone marrow mesenchymal stem cell transplantation in patients with multiple sclerosis: a pilot study
    Yamout, B.; Hourani, R.; Salti, H.; Barada, W.; El-Hajj, T.; Al-Kutoubi, A.; Herlopian, A.; Baz, E.K.; Mahfouz, R.; Khalil-Hamdan, R.; Kreidieh, N.M.; El-Sabban, M.; Bazarbachi, A.
  • Functional exosome-mimic for delivery of siRNA to cancer: in vitro and in vivo evaluation
    Yang, Z.; Xie, J.; Zhu, J.; Kang, C.; Chiang, C.; Wang, X.; Kuang, T.; Chen, F.; Chen, Z.; Zhang, A.; Yu, B.; Lee, R.J.; Teng, L.; Lee, L.J.
  • Virus-mimetic fusogenic exosomes for direct delivery of integral membrane proteins to target cell membranes
    Yang, Y.; Hong, Y.; Nam, G.H.; Chung, J.H.; Koh, E.; Kim, I.S.
  • Exosome engineering for efficient intracellular delivery of soluble proteins using optically reversible protein-protein interaction module
    Yim, N.; Ryu, S.W.; Choi, K.; Lee, K.R.; Lee, S.; Choi, H.; Kim, J.; Shaker, M.R.; Sun, W.; Park, J.H.; Kim, D.; Heo, W.D.; Choi, C.
  • Generation of nanovesicles with sliced cellular membrane fragments for exogenous material delivery
    Yoon, J.; Jo, W.; Jeong, D.; Kim, J.; Jeong, H.; Park, J.
  • TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy
    Yuan, Z.; Kolluri, K.K.; Gowers, K.H.; Janes, S.M.
  • Exosomes purified from a single cell type have diverse morphology
    Zabeo, D.; Cvjetkovic, A.; Lasser, C.; Schorb, M.; Lotvall, J.; Hoog, J.L.
  • Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapy
    Zhang, Y.; Peng, L.; Mumper, R.J.; Huang, L.
  • Multifunctional transmembrane protein ligands for cell-specific targeting of plasma membrane-derived vesicles
    Zhao, C.; Busch, D.J.; Vershel, C.P.; Stachowiak, J.C.
  • Monitoring the Rab27 associated exosome pathway using nanoparticle tracking analysis
    Zheng, Y.; Campbell, E.C.; Lucocq, J.; Riches, A.; Powis, S.J.
  • Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro
    Zhou, Y.; Xu, H.; Xu, W.; Wang, B.; Wu, H.; Tao, Y.; Zhang, B.; Wang, M.; Mao, F.; Yan, Y.; Gao, S.; Gu, H.; Zhu, W.; Qian, H.
  • Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice
    Zhu, Y.G.; Feng, X.M.; Abbott, J.; Fang, X.H.; Hao, Q.; Monsel, A.; Qu, J.M.; Matthay, M.A.; Lee, J.W.
  • Treatment of brain inflammatory diseases by delivering exosome encapsulated anti-inflammatory drugs from the nasal region to the brain
    Zhuang, X.; Xiang, X.; Grizzle, W.; Sun, D.; Zhang, S.; Axtell, R.C.; Ju, S.; Mu, J.; Zhang, L.; Steinman, L.; Miller, D.; Zhang, H.G.
  • Eradication of established murine tumors using a novel cell-free vaccine: dendritic cell-derived exosomes
    Zitvogel, L.; Regnault, A.; Lozier, A.; Wolfers, J.; Flament, C.; Tenza, D.; Ricciardi-Castagnoli, P.; Raposo, G.; Amigorena, S.
  • Recovery of extracellular vesicles from human breast milk is influenced by sample collection and vesicle isolation procedures
    Zonneveld, M.I.; Brisson, A.R.; van Herwijnen, M.J.; Tan, S.; van de Lest, C.H.; Redegeld, F.A.; Garssen, J.; Wauben, M.H.; Nolte-'t Hoen, E.N.
  • Mutant KRAS is a druggable target for pancreatic cancer
    Zorde Khvalevsky, E.; Gabai, R.; Rachmut, I.H.; Horwitz, E.; Brunschwig, Z.; Orbach, A.; Shemi, A.; Golan, T.; Domb, A.J.; Yavin, E.; Giladi, H.; Rivkin, L.; Simerzin, A.; Eliakim, R.; Khalaileh, A.; Hubert, A.; Lahav, M.; Kopelman, Y.; Goldin, E.; Dancour, A.; Hants, Y.; Arbel-Alon, S.; Abramovitch, R.; Galun, E.

You’re reading a free preview. Subscribe to read the entire article.

Try 2 weeks free now

DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

or browse the journals available

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial

Interested in DeepDyve for your group?
Try 2 weeks free now